1. Микрофлора пищеварительного тракта. Под ред. А.И.Хавкина. Фонд социальной педиатрии. 2007. Гл. 2; с. 17–119.
2. Захарова И.Н., Дмитриева Ю.А., Суркова Е.Н., Бегиашвили Л.В. Формирование микробиоценоза кишечника у детей, находящихся на естественном и искусственном вскармливании. Вопр. совр. педиатрии. 2010; 9 (2): 103–8.
3. Захарова И.Н., Сугян Н.Г., Дмитриева Ю.А. Формирование кишечной микробиоты первого полугодия жизни и характер вскармливания. Вопр. практич. педиатрии. 2010; 5 (5): 115–21.
4. Polonovsky M, Lespagnol A. Nouvelles acquisitions sur les composes glucidiques du lait de femme. Bull Soc Chim Biol 1933; 15: 320–49.
5. Mountzouris KC, McCartney AL, Gibson GR. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr 2002; 87: 405–20.
6. Morrow AL, Ruiz-Palacios GM, Altaye M et al. Human milk oligosaccharides are associated with protection against diarrhea in breastfed infants. J Pediatr 2004; 145: 297–303.
7. Jiang X, Huang P, Zhong W et al. Human milk contains elements that block binding of noroviruses to human histo-blood group antigensin saliva. J Infect Dis 2004; 190: 18509.
8. Crane JK, Azar SS, Stam A, Newborg DC. Oligosaccharides from human milk block binding and activity of the Escherichia coli heat-stable enterotoxin (STa) in T84 intestinal cells. J Nutr 1994; 124: 2358–64.
9. Куваева И. Б., Ладодо К.С. Микроэкологические и иммунные нарушения у детей. М.: Медицина, 1991.
10. Fernandez L, Langa S, Martin V et al. The human milk microbiota: Origin and potential roles in health and disease. Pharmacol Res 2013; 69; 1–10.
11. Heikkila MP, Saris PEJ. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol 2003; 95: 471–8.
12. Martin R, Langa S, Reviriego C et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003; 143: 754–8.
13. Heikkila MP, Saris PEJ. Inhibition of Staphylococcus aureus by the commensal bacteia of human milk. J Appl Microbiol 2003; 95: 471–8.
14. Gavin A, Ostovar K. Microbiological characterization of human milk. J Food Protect 1977; 40: 614–6.
15. Martin R, Olivares M et al. Probiotic potential of 3 lactobacilli strains isolated from breast milk. J Hum Lact 2005; 21: 8–17.
16. Grönlund MM, Gueimonde M, Laitinen K et al. Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007; 37 (12): 1764–72. Epub 2007.
17. Martin R, Jiminez E, Heilig HG et al. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environment Microbiol 2009; 75: 965–9.
18. Martin R, Heilig HG, Zoetendal EG et al. Cultivation-independent assessment of the bacterial diversity of breast milk among healthy women. Res Microbiol 2007; 158: 31–7.
19. Martin R, Heilig HG, Zoetendal EG et al. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol 2007; 103: 2638–44.
20. Hunt KM, Foster JA, Forney LJ et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS ONE 2011; 6: e21313.
21. Grice EA, Kong HH, Conlan S et al. NISC Comparative Sequencing Program, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324: 1190–2.
22. Langa S, Maldonado A, Delgado S et al. Characterization of Lactobacillus salivarius CECT 5713, a strain isolated from human milk: from genotype to phenotype. Appl Microbiol Biotechnol 2012; 94: 1279–87.
23. Perez PF, Doré J, Leclerc M et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells. Pediatrics 2007; 119: e724–32.
24. Reid G. Regulatory and clinical aspects of dairy probiotics. FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina, 2001; 1–34.
25. Matsumoto M, Ohishi H, Benno Y. H+-ATPase activity in Bidobacterium with special reference to acid tolerance. Int J Food Microbiol 2004; 93: 109–13.
26. Acharya MR, Shah PK. Selection of human isolates of Bifidobacteria for their use as probiotics. Appl Biochem Biotechnol 2002; 102–103: 81–98.
27. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol 1998. Lett 167: 185–9.
28. Langhendries JP, Detry J, Van HJ et al. Effect of fermented infant formula containing variable Bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 1995; 21: 177–81.
29. Holscher HD, Czerkies LA, Cekola P et al. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 2012; 36 (Suppl. 1): 106S–17S.
30. Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatr Res 2006; 60 (2): 221–4.
31. Isolauri E, Arvola T, Sütas Y et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30 (11): 1604–10.
32. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004; 38 (3): 288–92.
33. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115 (1): 5–9.
34. Corrêa NB, Péret Filho LA, Penna FJ et al. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005; 39 (5): 385–9.
35. Stratiki E, Sevastiadou S, Stamouli K et al. Effect of oral Bifidobacterium lactis on the intestinal permeability and the growth of preterm infants. Europediatrics 2006; abstr.
36. Mohan R, Koebnick C, Blaut M et al. Microbial colonization of the gastrointestinal tract of preterm infants: diversity and new ways for prevention of infections. Europediatrics 2006; abstr.
37. Захарова И.Н., Свинцицкая В.И., Елезова Л.И., Гадзова И.С. Клиническая эффективность синбиотика, содержащего Bifidobacterium BB12, Lactobacillis acidophilus LA-5 и фруктоолигосахариды для коррекции нарушений микробиоценоза кишечника у детей. Вопр. практич. педиатрии; 6 (2): 63–6.
38. Szajewska H, Guandalini S, Morelli L et al. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr 2010; 51 (2): 203–9.

И.Н.Захарова, Ю.А.Дмитриева

ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава РФ, Москва